Which medication helps to stabilize mast cells in asthma treatment?

Cromolyn sodium is a medication that plays a crucial role in the management of asthma by stabilizing mast cells. Mast cells are a type of immune cell that releases histamine and other inflammatory mediators during an allergic reaction or asthma exacerbation. By preventing the release of these mediators, cromolyn sodium helps to reduce the frequency and severity of asthma attacks, particularly those triggered by allergens or exercise.

This mechanism of action makes cromolyn sodium particularly useful as a preventive treatment. It is often used in pediatric patients and is known for its safety profile, making it suitable for children with asthma who require long-term management to control symptoms and improve overall lung function.

In contrast, other options listed, while important in asthma management, have different mechanisms of action. Fluticasone is a corticosteroid that reduces inflammation; montelukast is a leukotriene receptor antagonist that helps alleviate bronchoconstriction; and omalizumab is an antibody that targets immunoglobulin E (IgE) to prevent allergic reactions. Each of these medications serves a unique purpose in asthma therapy, but cromolyn sodium is specifically linked to mast cell stabilization.